...
首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Comparison of accelerated and real-time cyclosporine A release testing from poly(l-lactide-co-trimethylene carbonate) matrices.
【24h】

Comparison of accelerated and real-time cyclosporine A release testing from poly(l-lactide-co-trimethylene carbonate) matrices.

机译:从聚(1-丙交酯-碳酸三亚甲基酯共)基质中加速和实时环孢霉素A释放测试的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Cyclosporine A (CyA) is a cyclic undecapep-tide, used in prophylaxis and therapy of graft rejection in all types of solid organ and bone narrow transplantations, as well as in treatment of a number of autoimmune diseases. However, prolonged repeated treatment with CyA may cause many side effects like nephrotoxicity, gingival hyperplasia and neurological disorders (1). Several controlled delivery systems of CyA has been studied so far as microspheres and nanospheres based on biodegradable aliphatic polyesters including poly(lactide-co-glycolide), polylactide, and poly(e-caprolactone) (1, 2). Copolymers of TMC with L-lactide may be interesting in developing alternative delivery systems of cyclosporine A. PTMC degrades by surface erosion without acidic products, that could allow to obtain zero order drug release kinetics as well as protection of labile drug molecules (3, 4).
机译:环孢菌素A(CyA)是一种环状十一肽,可用于预防和治疗各种类型的实体器官和骨狭窄移植物中的移植排斥,以及用于治疗多种自身免疫性疾病。但是,长时间重复使用CyA可能会引起许多副作用,例如肾毒性,牙龈增生和神经系统疾病(1)。迄今为止,已经研究了CyA的几种受控递送系统,包括基于可生物降解的脂族聚酯的微球和纳米球,包括聚丙交酯-乙交酯,聚丙交酯和聚己内酯(1,2)。 TMC与L-丙交酯的共聚物在开发环孢霉素A的替代递送系统中可能会令人感兴趣.PTMC通过表面腐蚀而降解,而没有酸性产物,这可以使药物获得零级释放动力学并保护不稳定的药物分子(3、4 )。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号